HomeVALN • NASDAQ
add
Valneva SE
Nakaraang pagsara
$7.01
Sakop ng araw
$6.87 - $7.19
Sakop ng taon
$3.62 - $9.50
Market cap
597.03M USD
Average na Volume
99.55K
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 52.94M | 26.36% |
Gastos sa pagpapatakbo | 20.57M | -30.13% |
Net na kita | -36.99M | -15.02% |
Net profit margin | -69.86 | 8.98% |
Kita sa bawat share | -0.54 | -14.57% |
EBITDA | -20.14M | 28.97% |
Aktuwal na % ng binabayarang buwis | -14.34% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 168.27M | 33.46% |
Kabuuang asset | 500.03M | 8.69% |
Kabuuang sagutin | 318.78M | -3.93% |
Kabuuang equity | 181.25M | — |
Natitirang share | 162.40M | — |
Presyo para makapag-book | 6.26 | — |
Return on assets | -10.05% | — |
Return on capital | -12.52% | — |
Cash Flow
Net change in cash
| (EUR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -36.99M | -15.02% |
Cash mula sa mga operasyon | 9.53M | 114.45% |
Cash mula sa pag-invest | 4.69M | 128.73% |
Cash mula sa financing | -4.59M | -112.42% |
Net change in cash | 11.94M | 126.42% |
Malayang cash flow | 4.52M | 107.93% |
Tungkol
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Itinatag
2013
Website
Mga Empleyado
713
